Log in

NASDAQ:MASIMasimo Stock Price, Forecast & News

$217.08
-2.16 (-0.99 %)
(As of 08/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$214.15
Now: $217.08
$220.41
50-Day Range
$217.19
MA: $228.19
$246.81
52-Week Range
$139.36
Now: $217.08
$258.00
Volume381,736 shs
Average Volume563,872 shs
Market Capitalization$11.93 billion
P/E Ratio56.24
Dividend YieldN/A
Beta0.87
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. In addition, the company offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, and handheld capnograph and capnometer devices; and O3 regional oximetry for tissue oxygen saturation measurement. Further, it provides Patient SafetyNet, a surveillance, remote monitoring, and clinician notification solution; MyView, a wireless presence-detection system; and connectivity devices. Additionally, the company offers Trace, a patient data visualization and reporting software that monitors Masimo Root and Radical-7. The company provides its products directly, as well as through distributors and original equipment manufacturers partners to hospitals, emergency medical service providers, physician offices, long term care facilities, veterinarians and consumers. Masimo Corporation was founded in 1989 and is headquartered in Irvine, California.
Read More
Masimo logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.4Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.22 out of 5 stars


Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:MASI
CUSIP57479510
Phone949-297-7000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$937.84 million
Cash Flow$3.75 per share
Book Value$24.47 per share

Profitability

Net Income$196.22 million

Miscellaneous

Employees1,600
Market Cap$11.93 billion
Next Earnings Date11/4/2020 (Estimated)
OptionableOptionable
$217.08
-2.16 (-0.99 %)
(As of 08/7/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MASI News and Ratings via Email

Sign-up to receive the latest news and ratings for MASI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Masimo (NASDAQ:MASI) Frequently Asked Questions

How has Masimo's stock been impacted by COVID-19 (Coronavirus)?

Masimo's stock was trading at $182.64 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, MASI shares have increased by 18.9% and is now trading at $217.08.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Masimo?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Masimo in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Masimo
.

When is Masimo's next earnings date?

Masimo is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Masimo
.

How were Masimo's earnings last quarter?

Masimo Co. (NASDAQ:MASI) announced its earnings results on Tuesday, July, 28th. The medical equipment provider reported $0.85 earnings per share for the quarter, topping analysts' consensus estimates of $0.78 by $0.07. The medical equipment provider earned $301 million during the quarter, compared to analysts' expectations of $290.09 million. Masimo had a net margin of 21.22% and a return on equity of 16.49%. The company's revenue was up 30.9% on a year-over-year basis. During the same period in the previous year, the firm earned $0.76 earnings per share.
View Masimo's earnings history
.

What price target have analysts set for MASI?

7 equities research analysts have issued twelve-month target prices for Masimo's stock. Their forecasts range from $175.00 to $255.00. On average, they expect Masimo's share price to reach $221.17 in the next year. This suggests a possible upside of 1.9% from the stock's current price.
View analysts' price targets for Masimo
.

Has Masimo been receiving favorable news coverage?

Press coverage about MASI stock has been trending very positive this week, InfoTrie reports. The research group identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Masimo earned a daily sentiment score of 4.0 on InfoTrie's scale. They also gave news coverage about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days.
View the latest news about Masimo
.

Are investors shorting Masimo?

Masimo saw a decline in short interest in July. As of July 15th, there was short interest totaling 925,800 shares, a decline of 31.4% from the June 30th total of 1,350,000 shares. Based on an average daily volume of 647,200 shares, the short-interest ratio is presently 1.4 days. Currently, 1.9% of the shares of the stock are short sold.
View Masimo's Current Options Chain
.

Who are some of Masimo's key competitors?

What other stocks do shareholders of Masimo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Masimo investors own include NVIDIA (NVDA), Alibaba Group (BABA), Netflix (NFLX), Walt Disney (DIS), Shopify (SHOP), Paypal (PYPL), Okta (OKTA), Mastercard (MA), Trade Desk (TTD) and Twilio (TWLO).

Who are Masimo's key executives?

Masimo's management team includes the following people:
  • Mr. Joseph E. Kiani, Founder, CEO & Chairman (Age 54)
  • Mr. Micah Young, Exec. VP of Fin. & CFO (Age 40)
  • Mr. Anand Sampath, Chief Operating Officer (Age 53)
  • Dr. Steven J. Barker, Chairman of Scientific Advisory Board, Chief Science Officer & Director (Age 74)
  • Mr. Thomas Samuel McClenahan, Exec. VP, Gen. Counsel & Corp. Sec. (Age 46)

What is Masimo's stock symbol?

Masimo trades on the NASDAQ under the ticker symbol "MASI."

Who are Masimo's major shareholders?

Masimo's stock is owned by a number of institutional and retail investors. Top institutional investors include Victory Capital Management Inc. (1.37%), Raymond James & Associates (0.57%), Sumitomo Mitsui Trust Holdings Inc. (0.38%), Swiss National Bank (0.37%), Obermeyer Wood Investment Counsel Lllp (0.36%) and UBS Group AG (0.36%). Company insiders that own Masimo stock include Adam Mikkelson, Anand Sampath, Bilal Muhsin, H Michael Cohen, Joe E Kiani, Jon Coleman, Micah W Young, Ramshorst David J Van, Sanford Fitch, Steven Barker, Thomas Samuel Mcclenahan and Yongsam Lee.
View institutional ownership trends for Masimo
.

Which institutional investors are selling Masimo stock?

MASI stock was sold by a variety of institutional investors in the last quarter, including BNP PARIBAS ASSET MANAGEMENT Holding S.A., Scout Investments Inc., UBS Group AG, Mutual of America Capital Management LLC, Victory Capital Management Inc., Candriam Luxembourg S.C.A., New York State Common Retirement Fund, and Mckinley Capital Management LLC Delaware. Company insiders that have sold Masimo company stock in the last year include Adam Mikkelson, Anand Sampath, Bilal Muhsin, H Michael Cohen, Joe E Kiani, Jon Coleman, Micah W Young, Ramshorst David J Van, Sanford Fitch, Steven Barker, Thomas Samuel Mcclenahan, and Yongsam Lee.
View insider buying and selling activity for Masimo
.

Which institutional investors are buying Masimo stock?

MASI stock was purchased by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Trust Holdings Inc., Swiss National Bank, First Trust Advisors LP, Assenagon Asset Management S.A., Andra AP fonden, State of Alaska Department of Revenue, Rathbone Brothers plc, and Nisa Investment Advisors LLC.
View insider buying and selling activity for Masimo
.

How do I buy shares of Masimo?

Shares of MASI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Masimo's stock price today?

One share of MASI stock can currently be purchased for approximately $217.08.

How big of a company is Masimo?

Masimo has a market capitalization of $11.93 billion and generates $937.84 million in revenue each year. The medical equipment provider earns $196.22 million in net income (profit) each year or $3.22 on an earnings per share basis. Masimo employs 1,600 workers across the globe.

What is Masimo's official website?

The official website for Masimo is www.masimo.com.

How can I contact Masimo?

Masimo's mailing address is 52 DISCOVERY, IRVINE CA, 92618. The medical equipment provider can be reached via phone at 949-297-7000 or via email at [email protected]

This page was last updated on 8/8/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.